Nongenetic engineering nanozyme proximity labeling reveals subcellular in situ interactomes and trafficking pathways of nanoparticles
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2521555123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Chao Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Cancer Hospital, Zhejiang Provincial Key Laboratory of Protein Detection Technology and Diagnostic Equipment, Hangzhou Institute of Medicine…. Hauptthemen laut MEDLINE: Nanoparticles, Magnetite Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
Elucidating the dynamic interactions between nanocarriers and cellular machinery is critical for advancing targeted nanomedicine. However, the optical microscopy imaging techniques can only provide a generalized view of nanomedicine localization. Proteomics approaches require cell lysis which disrupt native protein coronas during isolation, obscuring real-time intracellular trafficking mechanisms. Although proximity labeling enables in situ investigation of intracellular protein–protein interactions, it relies on genetically engineered enzyme fusion, thus limiting applicability across diverse systems. In this study, we report nanozyme proximity labeling (NPL), a genetic engineering-free strategy that harnesses the intrinsic peroxidase activity of Fe 3 O 4 nanoparticles (NPs) to biotinylate proximal proteins within live cells. NPL achieves rapid biotinylation of NP-interacting proteins during intracellular transit. Using streptavidin pulldown and LC–MS/MS, we mapped high-fidelity in situ interactomes and suggested distinct trafficking pathways for mitochondrial-targeted Fe 3 O 4 @TPP NPs and nontargeted Fe 3 O 4 NPs. Our NPL interrogates the native NP–protein corona–organelle interfaces, offering a generalizable platform to decipher subcellular targeting mechanisms and accelerate nanomedicine optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Cancer Hospital, Zhejiang Provincial Key Laboratory of Protein Detection Technology and Diagnostic Equipment, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, People's Rep…
- Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau 999078, People's Republic of China.
- Mechanobiology Institute, National University of Singapore, Singapore 117411, Singapore.
ORCID-Profile: Chao Jiang, Zirui Zhuang, Yunlu Dai, Ji Jing, Yuan Liu
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
Zitieren
APA
Jiang, C., Fu, Y., Jin, B., Gao, R., Li, W., Wang, Z., Huang, H., Zhuang, Z., Dai, Y., Jing, J., & Liu, Y. (2026). Nongenetic engineering nanozyme proximity labeling reveals subcellular in situ interactomes and trafficking pathways of nanoparticles. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2521555123
Vancouver
Jiang C, Fu Y, Jin B, Gao R, Li W, Wang Z, et al. Nongenetic engineering nanozyme proximity labeling reveals subcellular in situ interactomes and trafficking pathways of nanoparticles. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2521555123
BibTeX
@article{Jiang2026,
author = {Jiang, Chao and Fu, Yiyang and Jin, Baichuan and Gao, Rongzi and Li, Wenwei and Wang, Ze and Huang, Haozhe and Zhuang, Zirui and Dai, Yunlu and Jing, Ji and Liu, Yuan},
title = {Nongenetic engineering nanozyme proximity labeling reveals subcellular in situ interactomes and trafficking pathways of nanoparticles},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2521555123}
}
EUVIMED